Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer
Concurrent Use of Lymphoseek and Indocyanine Green for Sentinel Lymph Node Detection in Endometrial Cancer - a Prospective Study
Sponsor: Stanford University
Terminated
Efficacy
Other terminated trials from Stanford University
Other Endometrial Cancer trials with similar outcome
A PHASE2 clinical study on Endometrial Cancer, this trial is terminated or withdrawn. The trial is conducted by Stanford University and has accumulated 8 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Nov 2023 — Jul 2024 [monthly]
Terminated PHASE2
Status: Suspended → Terminated
-
Jul 2022 — Nov 2023 [monthly]
Suspended PHASE2
-
Sep 2021 — Jul 2022 [monthly]
Suspended PHASE2
Status: Recruiting → Suspended
▶ Show 3 earlier versions
-
Mar 2021 — Sep 2021 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Not Yet Recruiting PHASE2
-
Sep 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Stanford University
For direct contact, visit the study record on ClinicalTrials.gov .